Emjard 25
- Emjard is a medication for adults with type 2 diabetes mellitus.
- It improves glycemic control when combined with diet and exercise.
- By inhibiting sodium glucose co-transporter-2 (SGLT-2) in the kidneys:
- Increases glucose excretion
- Promotes weight loss
- Reduces blood pressure
- Emjard is available in tablet form for once-daily administration, with or without food.
- Patients should follow recommended dosages and consult healthcare professionals for optimal diabetes management.
Emjard M 12.5/500
- Empagliflozin-Metformin: A potent combination for type 2 diabetes management.
- Controls blood sugar levels alongside diet and exercise regimen.
- Empagliflozin reduces glucose reabsorption by the kidneys.
- Metformin lowers glucose production and enhances insulin sensitivity.
- Ideal for patients not adequately controlled with Metformin alone or in combination therapy.
Emjard M 5/500
- Empagliflozin-Metformin: A potent combination for type 2 diabetes management.
- Controls blood sugar levels alongside diet and exercise regimen.
- Empagliflozin reduces glucose reabsorption by the kidneys.
- Metformin lowers glucose production and enhances insulin sensitivity.
- Ideal for patients not adequately controlled with Metformin alone or in combination therapy.
Jardian 10
- Explore Jardian, an innovative treatment for adults with type 2 diabetes mellitus
- Sodium glucose co-transporter-2 (SGLT-2) inhibitor that enhances renal glucose excretion
- Improves glycemic control and aids in managing cardiovascular risks
- Minimal side effects and comprehensive support on dosage, interactions, and precautions
Jardimet 5/500
- Explore Jardimet, an effective treatment for adults with type 2 diabetes mellitus, available at Live Pharmacy.
- Combines Empagliflozin and Metformin Hydrochloride to enhance glycemic control beyond diet and exercise alone.
- Empagliflozin reduces renal glucose reabsorption, increasing urinary glucose excretion.
- Metformin improves insulin sensitivity, lowers hepatic glucose production, and aids in peripheral glucose uptake.
- Individualized dosing ensures effectiveness with minimal gastrointestinal side effects, supporting optimal diabetes management.